N. Adab, A. Jacoby, D. Smith, and D. Chadwick, Additional educational needs in children born to mothers with epilepsy, Journal of Neurology, Neurosurgery & Psychiatry, vol.70, issue.1, pp.15-21, 2001.
DOI : 10.1136/jnnp.70.1.15

S. Ahmad, L. J. Fowler, and P. S. Whitton, Lamotrigine, carbamazepine and phenytoin differentially alter extracellular levels of 5-hydroxytryptamine, dopamine and amino acids, Epilepsy Research, vol.63, issue.2-3, pp.141-149, 2005.
DOI : 10.1016/j.eplepsyres.2005.02.002

A. Bartoli, R. Marchiselli, and G. Gatti, A Rapid and Specific Assay for the Determination of Lamotrigine in Human Plasma by Normal-Phase HPLC, Therapeutic Drug Monitoring, vol.19, issue.1, pp.100-107, 1997.
DOI : 10.1097/00007691-199702000-00020

P. Bittigau, M. Sifringer, K. Genz, E. Reith, D. Pospischil et al., Antiepileptic drugs and apoptotic neurodegeneration in the developing brain, Proc. Natl. Acad. Sci. U.S.A. 99, pp.15089-15094, 2002.
DOI : 10.1073/pnas.222550499

M. M. Castel-branco, A. C. Falcao, I. V. Figueiredo, and M. M. Caramona, Lamotrigine pharmacokinetic/pharmacodynamic modelling in rats, Fundamental and Clinical Pharmacology, vol.27, issue.5, pp.669-675, 2005.
DOI : 10.1038/sj.bjp.0703337

P. Czapinski, B. Blaszczyk, and S. J. Czuczwar, Mechanisms of Action of Antiepileptic Drugs, Current Topics in Medicinal Chemistry, vol.5, issue.1, pp.3-14, 2005.
DOI : 10.2174/1568026053386962

B. R. Danielsson, K. Lansdell, L. Patmore, and T. Tomson, Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents, Epilepsy Research, vol.63, issue.1, pp.17-25, 2005.
DOI : 10.1016/j.eplepsyres.2004.10.002

V. Des-portes, L. Abaoub, A. Joannard, I. Souville, F. Francis et al., So-called ???cryptogenic??? partial seizures resulting from a subtle cortical dysgenesis due to adoublecortin gene mutation, Seizure, vol.11, issue.4, pp.273-277, 2002.
DOI : 10.1053/seiz.2001.0607

L. B. Holmes, The teratogenicity of anticonvulsant drugs: a progress report, Journal of Medical Genetics, vol.39, issue.4, 2002.
DOI : 10.1136/jmg.39.4.245

S. Koch, K. Titze, R. B. Zimmermann, M. Schroder, U. Lehmkuhl et al., Long-Term Neuropsychological Consequences of Maternal Epilepsy and Anticonvulsant Treatment During Pregnancy for School-Age Children and Adolescents, Epilepsia, vol.34, issue.9, 1999.
DOI : 10.1016/S0140-6736(68)91781-9

H. Komuro and P. Rakic, Modulation of neuronal migration by NMDA receptors, Science, vol.260, issue.5104, pp.95-97, 1993.
DOI : 10.1126/science.8096653

M. J. Leach, A. D. Randall, A. Stefani, and A. H. Hainsworth, Lamotrigine: mechanisms of action, Antiepileptic Drugs. Lippincott Williams and Wilkins, pp.364-369, 2002.

J. J. Loturco, D. F. Owens, M. J. Heath, M. B. Davis, and A. R. Kriegstein, GABA and glutamate depolarize cortical progenitor cells and inhibit DNA synthesis, Neuron, vol.15, issue.6, 1995.
DOI : 10.1016/0896-6273(95)90008-X

J. B. Manent and A. Represa, Neurotransmitters and Brain Maturation: Early Paracrine Actions of GABA and Glutamate Modulate Neuronal Migration, The Neuroscientist, vol.17, issue.3, pp.268-279, 2007.
DOI : 10.1177/1073858406298918
URL : https://hal.archives-ouvertes.fr/inserm-00483861

J. B. Manent, M. Demarque, I. Jorquera, C. Pellegrino, B. Ari et al., A Noncanonical Release of GABA and Glutamate Modulates Neuronal Migration, Journal of Neuroscience, vol.25, issue.19, pp.4755-4765, 2005.
DOI : 10.1523/JNEUROSCI.0553-05.2005
URL : https://hal.archives-ouvertes.fr/inserm-00484364

J. B. Manent, I. Jorquera, B. Ari, Y. Aniksztejn, L. Represa et al., Glutamate Acting on AMPA But Not NMDA Receptors Modulates the Migration of Hippocampal Interneurons, Journal of Neuroscience, vol.26, issue.22, pp.5901-5909, 2006.
DOI : 10.1523/JNEUROSCI.1033-06.2006
URL : https://hal.archives-ouvertes.fr/inserm-00483918

J. B. Manent, I. Jorquera, I. Mazzucchelli, A. Depaulis, E. Perucca et al., Fetal Exposure to GABA-Acting Antiepileptic Drugs Generates Hippocampal and Cortical Dysplasias, Epilepsia, vol.305, issue.8, pp.684-693, 2007.
DOI : 10.1111/j.1528-1157.1999.tb00913.x
URL : https://hal.archives-ouvertes.fr/inserm-00384325

K. J. Meador, G. A. Baker, R. H. Finnell, L. A. Kalayjian, J. D. Liporace et al., In utero antiepileptic drug exposure: Fetal death and malformations, utero antiepileptic drug exposure: fetal death and malformations, pp.407-412, 2006.
DOI : 10.1212/01.wnl.0000227919.81208.b2

E. Perucca, Is There a Role for Therapeutic Drug Monitoring of New Anticonvulsants?, Clinical Pharmacokinetics, vol.48, issue.3, 2000.
DOI : 10.2165/00003088-200038030-00001

E. Perucca, Clinical pharmacology and therapeutic use of the new antiepileptic drugs Fundamental & Clinical Pharmacology 15, pp.405-417, 2001.

E. Perucca, Birth defects after prenatal exposure to antiepileptic drugs, The Lancet Neurology, vol.4, issue.11, pp.781-786, 2005.
DOI : 10.1016/S1474-4422(05)70224-6

H. E. Shannon, E. L. Eberle, and S. C. Peters, Comparison of the effects of anticonvulsant drugs with diverse mechanisms of action in the formalin test in rats, Neuropharmacology, vol.48, issue.7, 2005.
DOI : 10.1016/j.neuropharm.2005.01.013

L. J. Stephen and M. J. Brodie, Lamotrigine: clinical efficacy and use in epilepsy, 2002.

G. Tringali, J. M. Aubry, P. Navarra, and G. Pozzoli, Lamotrigine inhibits basal and Na+-stimulated, but not Ca2+-stimulated, release of corticotropin-releasing hormone from the rat hypothalamus, Psychopharmacology, vol.430, issue.Suppl 2, pp.386-392, 2006.
DOI : 10.1007/s00213-006-0539-4

J. Vinten, N. Adab, U. Kini, J. Gorry, J. Gregg et al., Neuropsychological effects of exposure to anticonvulsant medication in utero, Neurology, vol.64, issue.6, pp.949-954, 2005.
DOI : 10.1212/01.WNL.0000154514.82948.69